Molina Healthcare vs Vaxcyte

Molina Healthcare (MOH), health care, and Vaxcyte (PCVX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Molina Healthcare is worth $11.5B on the stock market and Vaxcyte $9.4B: Molina Healthcare is valued at 23% more. Over the past year Molina Healthcare's share price has moved +65.1% and Vaxcyte's +24.4%.

Key facts

Molina Healthcare market value
$11.5B
Vaxcyte market value
$9.4B
Molina Healthcare revenue
$45.4BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Molina Healthcare vs Vaxcyte: every measure side by side
Measure Molina Healthcare Vaxcyte
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$11.5Bhigher$9.4Blower
Revenue$45.4B—
Earnings$472Mhigher-$766.6Mlower
Employees19,000higher507lower
Total assets$15.6Bhigher$3Blower
Valuation
P/E——
P/S0.3—
P/B2.8lower3.6higher
Dividend yield0.00%0.00%
Profitability
Operating margin1.72%—
Balance sheet
Net assets$4.1Bhigher$2.7Blower
Total liabilities$11.5Bhigher$317.2Mlower
Total debt$3.8B—
Cash on hand$4.2Bhigher$174Mlower
Price change
Today-5.10%lower-3.59%higher
1 year+65.1%higher+24.4%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Vaxcyte only (2)

Percentages are each holding's share of that investor's reported portfolio. Who owns MOH · Who owns PCVX

Further comparisons

Learn

Questions and answers

Which is bigger, Molina Healthcare or Vaxcyte?

By market value, Molina Healthcare is the larger: $11.5B against $9.4B for Vaxcyte.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Molina Healthcare and Vaxcyte?

None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Molina Healthcare and 2 hold Vaxcyte.

Cite this page

Funkfolio, “Molina Healthcare vs Vaxcyte”, data as of 17 November 2026. https://funkfolio.com/compare/moh-vs-pcvx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.